Restart Life Sciences Corp.
HEAL
Classement en actions
#35835
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Prix de l'action
$0.05137558
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$3.21M
Changement (1 jour)
0.00%
Changement (1 an)
78.84%
Pays
CA
Échange Restart Life Sciences Corp. (HEAL)
Catégorie
Healthcare
Capitalisation boursière de Restart Life Sciences Corp.(HEAL)
Capitalisation boursière: $3.21M
En October 2026, Restart Life Sciences Corp. a une capitalisation boursière de $3.21M. Cela fait de Restart Life Sciences Corp. la 35835th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Restart Life Sciences Corp. du 2006 au 2026
HEAL par rapport au top 5 des plus populaires stocks
| Prix pour HEAL | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$35,109.65
$4.23M
|
$5.167T | +122,217,908.96% | ||
|
$34,075.05
$4.23M
|
$5.015T | +118,616,424.05% | ||
|
$27,916.28
$4.23M
|
$4.108T | +97,177,537.53% | ||
|
$26,513.14
$4.23M
|
$3.902T | +92,293,148.85% | ||
|
$18,274.65
$4.23M
|
$2.689T | +63,614,650.93% |
